Study Details
Full Title
A PHASE 3 STUDY TO EVALUATE THE SAFETY, TOLERABILITY, AND
IMMUNOGENICITY OF A RESPIRATORY SYNCYTIAL VIRUS VACCINE IN
CHILDREN AT HIGH RISK OF RSV DISEASE
IMMUNOGENICITY OF A RESPIRATORY SYNCYTIAL VIRUS VACCINE IN
CHILDREN AT HIGH RISK OF RSV DISEASE
Principal Investigator
Michael
Smith
Protocol Number
PRO00121136
Phase
III
Enrollment Status
Open to Enrollment